Cargando…

In Silico Multi-Target Approach Revealed Potential Lead Compounds as Scaffold for the Synthesis of Chemical Analogues Targeting SARS-CoV-2

SIMPLE SUMMARY: COVID-19 is an infectious disease caused by SARS-CoV-2. The virus has rapidly spread to humans, causing the ongoing coronavirus pandemic. Enormous progress in finding therapies has been made, but an effective therapy is still absent. In this study, we propose a computational strategy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trezza, Alfonso, Mugnaini, Claudia, Corelli, Federico, Santucci, Annalisa, Spiga, Ottavia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945274/ https://www.ncbi.nlm.nih.gov/pubmed/35336838 http://dx.doi.org/10.3390/biology11030465

Ejemplares similares

An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors
por: Trezza, Alfonso, et al.
Publicado: (2020)

From in silico to in vitro: a trip to reveal flavonoid binding on the Rattus norvegicus Kir6.1 ATP-sensitive inward rectifier potassium channel
por: Trezza, Alfonso, et al.
Publicado: (2018)

Pharmacological and In Silico Analysis of Oat Avenanthramides as EGFR Inhibitors: Effects on EGF-Induced Lung Cancer Cell Growth and Migration
por: Trabalzini, Lorenza, et al.
Publicado: (2022)

Machine learning application for development of a data-driven predictive model able to investigate quality of life scores in a rare disease
por: Spiga, Ottavia, et al.
Publicado: (2020)

A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization
por: Bongini, Pietro, et al.
Publicado: (2020)

The Impact of Artificial Intelligence in the Odyssey of Rare Diseases
por: Visibelli, Anna, et al.
Publicado: (2023)

The Selective CB2 Agonist COR167 Reduced Symptoms in a Mice Model of Trauma-Induced Peripheral Neuropathy through HDAC-1 Inhibition
por: Borgonetti, Vittoria, et al.
Publicado: (2023)

Functionalization of the Chalcone Scaffold for the Discovery of Novel Lead Compounds Targeting Fungal Infections
por: Bonvicini, Francesca, et al.
Publicado: (2019)

Ritanserin blocks Ca(V)1.2 channels in rat artery smooth muscles: electrophysiological, functional, and computational studies
por: Fusi, Fabio, et al.
Publicado: (2020)

ApreciseKUre: an approach of Precision Medicine in a Rare Disease
por: Spiga, Ottavia, et al.
Publicado: (2017)

In Silico Screening and Analysis of Broad-Spectrum Molecular Targets and Lead Compounds for Diarrhea Therapy
por: Ugboko, Harriet U, et al.
Publicado: (2019)

Chemoinformatic Database Building and in Silico Hit-Identification of Potential Multi-Targeting Bioactive Compounds Extracted from Mushroom Species
por: Maruca, Annalisa, et al.
Publicado: (2017)

Exploiting the Indole Scaffold to Design Compounds Binding to Different Pharmacological Targets †
por: Taliani, Sabrina, et al.
Publicado: (2020)

From compound to target: chemical proteomics and in silico screening identify Hsp90 and CDPK2 as putative targets in Plasmodium falciparum
por: Lauciello, Leonardo, et al.
Publicado: (2012)

In Silico Identification of Multi-Target Ligands as Promising Hit Compounds for Neurodegenerative Diseases Drug Development
por: Alov, Petko, et al.
Publicado: (2022)

Structural investigation of Rett-inducing MeCP2 mutations()
por: Spiga, Ottavia, et al.
Publicado: (2018)

Supporting Machine Learning Model in the Treatment of Chronic Pain
por: Visibelli, Anna, et al.
Publicado: (2023)

The Selective Rat Toxicant Norbormide Blocks K(ATP) Channels in Smooth Muscle Cells But Not in Insulin-Secreting Cells
por: Saponara, Simona, et al.
Publicado: (2019)

In Silico Design Strategies for the Production of Target Chemical Compounds Using Iterative Single-Level Linear Programming Problems
por: Shirai, Tomokazu, et al.
Publicado: (2022)

“Freedom of design” in chemical compound space: towards rational in silico design of molecules with targeted quantum-mechanical properties
por: Medrano Sandonas, Leonardo, et al.
Publicado: (2023)

HGDiscovery: An online tool providing functional and phenotypic information on novel variants of homogentisate 1,2- dioxigenase
por: Karmakar, Malancha, et al.
Publicado: (2022)

Adamantane-derived scaffolds targeting the sigma-2 receptor; an in vitro and in silico study
por: Alamri, Mohammed A., et al.
Publicado: (2021)

Identification of potential biological targets of oxindole scaffolds via in silico repositioning strategies
por: Tinivella, Annachiara, et al.
Publicado: (2022)

In silico studies of ASEM analogues targeting α7-nAChR and experimental verification
por: Zhou, Yang, et al.
Publicado: (2021)

Optimization of Pyrazole Compounds as Antibiotic Adjuvants Active against Colistin- and Carbapenem-Resistant Acinetobacter baumannii
por: Sannio, Filomena, et al.
Publicado: (2022)

Target-Based In Silico Screening for Phytoactive Compounds Targeting SARS-CoV-2
por: Zhao, Yong, et al.
Publicado: (2021)

The Pharmacogenetics of Cannabis in the Treatment of Chronic Pain
por: Poli, Paolo, et al.
Publicado: (2022)

In silico hippocampal modeling for multi-target pharmacotherapy in schizophrenia
por: Sherif, Mohamed A., et al.
Publicado: (2020)

In-silico target prediction by ensemble chemogenomic model based on multi-scale information of chemical structures and protein sequences
por: Yang, Su-Qing, et al.
Publicado: (2023)

Towards a Precision Medicine Approach Based on Machine Learning for Tailoring Medical Treatment in Alkaptonuria
por: Spiga, Ottavia, et al.
Publicado: (2021)

In Silico Identification and In Vitro Validation of Repurposed Compounds Targeting the RSV Polymerase
por: Xu, Eric, et al.
Publicado: (2023)

In Vitro and In Silico Characterization of an Antimalarial Compound with Antitumor Activity Targeting Human DNA Topoisomerase IB
por: Soren, Bini Chhetri, et al.
Publicado: (2021)

Hybridization of Curcumin Analogues with Cinnamic Acid Derivatives as Multi-Target Agents Against Alzheimer’s Disease Targets
por: Chainoglou, Eirini, et al.
Publicado: (2020)

In silico identification of novel lead compounds with AT(1 )receptor antagonist activity: successful application of chemical database screening protocol
por: Pal, Mahima, et al.
Publicado: (2012)

In Silico Identification of Tripeptides as Lead Compounds for the Design of KOR Ligands
por: Stefanucci, Azzurra, et al.
Publicado: (2021)

1,4-Dihydropyridine Derivatives: Dihydronicotinamide Analogues—Model Compounds Targeting Oxidative Stress
por: Velena, Astrida, et al.
Publicado: (2016)

In silico models for predicting vector control chemicals targeting Aedes aegypti
por: Devillers, J., et al.
Publicado: (2014)

Multiple chemical scaffolds inhibit a promising Leishmania drug target
por: Walkinshaw, Malcolm
Publicado: (2014)

Exploring the Multi–Target Neuroprotective Chemical Space of Benzofuran Scaffolds: A New Strategy in Drug Development for Alzheimer’s Disease
por: Cabrera-Pardo, Jaime R., et al.
Publicado: (2020)

Tacrine, Trolox and Tryptoline as Lead Compounds for the Design and Synthesis of Multi-target Agents for Alzheimer’s Disease Therapy
por: Teponnou, Gerard A. K., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ddd2tb5ns71eml11lq7ibig1tr